SNX19P3

Across TCGA pan-cancer cohorts, SNX19P3 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated SNX19P3 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher SNX19P3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SNX19P3 expression acts as an unfavorable survival marker, although some lineages such as PAAD and SKCM show a favorable association.

STAD, PAAD, and OV are the cancer types where SNX19P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	All	0.621	0.755	.001	40	view →
PAAD	DFS	Tertile	All	0.630	0.367	.006	32	view →
OV	OS	Quartile	III,IV	0.303	0.431	.010	32	view →
SKCM	OS	Quartile	III,IV	0.620	0.318	.001	27	view →
LUAD	DFS	Tertile	III,IV	0.560	0.873	.008	16	view →
CHOL	OS	Quartile	All	0.901	0.475	.008	15	view →
LGG	DFS	Median	All	0.694	0.784	.016	12	view →
PCPG	OS	Quartile	All	0.749	1.000	.011	12	view →
SARC	DFS	Tertile	All	0.370	0.635	<.001	11	view →
LIHC	DFS	Median	III,IV	0.213	0.419	.015	9	view →
COAD	OS	Median	IV	0.525	0.734	.014	7	view →
PRAD	OS	Quartile	All	0.636	0.924	.002	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

SNX19P3–STAD (OS)

Open the STAD breakdown →